A kind of reversible inhibitors of 26S proteasome chymotrypsin-like activity in mammalian cells, used for the treatment of multiple myeloma and the mantle cell lymphoma.
The main content of this product is bortezomib and the chemical name is [(1R)-3-methyl-1-[[(2S)-1-oxygen-3-phenyl-2-[(pyrazine carboxyl)amino]propyl]amino]butyl]boric acid.The chemical structure formula is as follows: C19H25BN4O4 and the molecular weight is 384.24.
For the treatment of multiple myeloma and the mantle cell lymphoma.
Intravenous drip.
Patients with bortezomib, boron or mannitol allergy.